Synergistic Application Strategy of Biotinylation and Affinity Tag Techniques in IL-2 Functional Research

Interleukin-2 (IL-2), one of the most functionally diverse cytokines in the immune system, is primarily produced by activated CD4-positive helper T cells and, to a lesser extent, by CD8-positive T cells and natural killer cells. By binding to different types of IL-2 receptor (IL-2R) complexes, IL-2 activates multiple downstream signaling pathways such as JAK-STAT, PI3K, and MAPK, thereby playing an irreplaceable dual regulatory role in processes like T cell proliferation and differentiation, B cell immunoglobulin production, NK cell cytolytic activity enhancement, and regulatory T cell survival maintenance—both promoting effector immune responses and maintaining immune tolerance. Given the complexity and clinical relevance of the IL-2 signaling axis, obtaining high-quality recombinant IL-2 protein reagents with native conformation, ease of detection, and the ability to mimic in vivo binding states has become a critical technological requirement in both basic immunology research and biopharmaceutical development.

The combined application of biotinylation and polyhistidine (His) tags represents a cutting-edge strategy in recombinant protein tool design. The extremely high affinity (Kd value up to 10⁻¹⁵ M) between biotin and streptavidin or avidin ensures excellent stability and specificity under various experimental conditions. This non-covalent interaction allows biotinylated proteins to be efficiently immobilized on solid-phase carriers or conjugated with streptavidin probes labeled with fluorophores or enzymes, facilitating applications such as protein interaction analysis, immunoassays, and cell sorting. Meanwhile, the C-terminal or N-terminal fused His tag (typically 6×His or 8×His) provides a standardized metal-chelating affinity chromatography (IMAC) purification method, ensuring high-purity protein recovery. For example, human IL-2 expressed in HEK293 eukaryotic systems with C-terminal His and Avi dual tags not only enables site-specific biotinylation via the unique lysine residue of the Avi tag under BirA enzyme catalysis (avoiding random chemical labeling that may interfere with active sites) but also allows efficient purification and detection through the His tag. This synergy ensures the homogeneity, activity, and experimental operability of the final product.

Analysis of existing similar products reveals that biotinylated human IL-2 His-tagged proteins typically use the mature peptide of human IL-2 (amino acid residues Ala21 to Thr153) as the core construct, expressed in HEK293 mammalian cells to ensure proper folding and glycosylation. The C-terminal 6×His-Avi tag results in a theoretical molecular weight of approximately 16–18 kDa, while glycosylation causes the apparent molecular weight to vary between 16–18 kDa and 35–50 kDa under reducing SDS-PAGE conditions. For quality control, such products typically require a purity of over 95% (verified by SDS-PAGE or Bis-Tris PAGE), endotoxin levels below 1 EU/μg, and validation of binding activity to anti-IL-2 antibodies or IL-2 receptor α-chain (CD25) via ELISA or bio-layer interferometry (BLI). For instance, some products exhibit ELISA binding EC₅₀ values as low as 6.45 ng/mL and BLI affinity constants of up to 8.60 nM, demonstrating the effective retention of binding activity facilitated by biotinylation tags.

Leveraging these technical advantages, biotinylated human IL-2 His-tagged proteins have demonstrated indispensable value in multiple cutting-edge research fields. In receptor-ligand interaction studies, this protein serves as a solid-phase or liquid-phase probe to analyze the binding kinetics and affinity differences between IL-2 and its trimeric receptor subunits (IL-2Rα/CD25, IL-2Rβ/CD122, IL-2Rγ/CD132), providing quantitative insights into the molecular mechanisms of IL-2 concentration-dependent signal transduction. In biopharmaceutical development, biotinylated IL-2 is a critical reagent for screening and characterizing anti-IL-2 neutralizing antibodies, fusion protein drugs, or engineered IL-2 variants (e.g., biased agonists), enabling high-throughput evaluation of candidate molecules' binding activity and competitiveness via platforms like ELISA, surface plasmon resonance (SPR), or BLI. Additionally, in cell function experiments, this protein can be used with streptavidin magnetic beads for sorting IL-2-responsive cells (e.g., CTLL-2 cell line) or signaling pathway analysis, with ED₅₀ values serving as key indicators for assessing the biological activity of different protein batches.

In summary, the combined strategy of biotinylation and His tags provides standardized tools for IL-2 functional research, offering high-affinity detection capability, high purity, and robust biological activity. The design of such proteins not only accounts for the natural structural characteristics of IL-2 as a glycosylated cytokine but also maximizes retention of its native conformation and signaling function through eukaryotic expression systems and site-specific biotinylation. As IL-2 engineering and novel immunotherapeutic strategies targeting the IL-2/IL-2R pathway continue to emerge, higher demands will be placed on the quality standards, batch consistency, and multi-scenario adaptability of biotinylated IL-2 proteins, driving further optimization and innovation in recombinant protein expression and labeling technologies.

Nanjing UA BIOSCIENCE, a domestic supplier specializing in recombinant protein development, offers a range of cytokine and drug target protein products, including IL-2 Protein, Mouse (Catalog No. UA040171). This mouse IL-2 protein is expressed in an E. coli system, purified to over 95% purity with endotoxin levels below 1.0 EU/μg, and has a molecular weight of approximately 15 kDa. It effectively promotes T lymphocyte proliferation and activation, making it suitable for applications such as murine immunology research, T cell function analysis, cell culture, and ELISA standards. With over 10 years of protein development experience, Nanjing UA BIOSCIENCE's product portfolio spans drug target proteins, cytokines, tool enzymes, and diagnostic antigens. The company is ISO9001 and ISO13485 certified, committed to providing high-quality recombinant protein reagents and professional services for biopharmaceutical R&D.